Jae‐Won Hyun

3.1k total citations
87 papers, 2.0k citations indexed

About

Jae‐Won Hyun is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Jae‐Won Hyun has authored 87 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pathology and Forensic Medicine, 52 papers in Neurology and 24 papers in Rheumatology. Recurrent topics in Jae‐Won Hyun's work include Multiple Sclerosis Research Studies (64 papers), Peripheral Neuropathies and Disorders (42 papers) and Systemic Lupus Erythematosus Research (20 papers). Jae‐Won Hyun is often cited by papers focused on Multiple Sclerosis Research Studies (64 papers), Peripheral Neuropathies and Disorders (42 papers) and Systemic Lupus Erythematosus Research (20 papers). Jae‐Won Hyun collaborates with scholars based in South Korea, United States and United Kingdom. Jae‐Won Hyun's co-authors include Ho Jin Kim, Su‐Hyun Kim, AeRan Joung, In Hye Jeong, So‐Young Huh, Jungnam Joo, Yeseul Kim, Min Su Park, Na-Young Park and Gayoung Kim and has published in prestigious journals such as PLoS ONE, Neurology and Scientific Reports.

In The Last Decade

Jae‐Won Hyun

85 papers receiving 1.9k citations

Peers

Jae‐Won Hyun

PFM

NEURO

RHEUM

ONCOL

IMMUN

A. Sebastian López‐Chiriboga United States

Su‐Hyun Kim South Korea

Noriko Isobe Japan

Lenka Novakova Sweden

AeRan Joung South Korea

Markus Axelsson Sweden

D. H. Miller United Kingdom

Sara Llufriú Spain

Yoshiki Takai Japan

In Hye Jeong South Korea

A. Sebastian López‐Chiriboga United States

Jae‐Won Hyun

1.2k ×0.9

PFM

2.3k ×2.0

NEURO

458 ×1.1

RHEUM

264 ×1.1

ONCOL

161 ×0.8

IMMUN

Citations per year, relative to Jae‐Won Hyun Jae‐Won Hyun (= 1×) peers A. Sebastian López‐Chiriboga

Countries citing papers authored by Jae‐Won Hyun

Since Specialization

Citations

This map shows the geographic impact of Jae‐Won Hyun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jae‐Won Hyun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jae‐Won Hyun more than expected).

Fields of papers citing papers by Jae‐Won Hyun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jae‐Won Hyun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jae‐Won Hyun. The network helps show where Jae‐Won Hyun may publish in the future.

Co-authorship network of co-authors of Jae‐Won Hyun

This figure shows the co-authorship network connecting the top 25 collaborators of Jae‐Won Hyun. A scholar is included among the top collaborators of Jae‐Won Hyun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jae‐Won Hyun. Jae‐Won Hyun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Ki Hoon, et al.. (2025). Discontinuation of Immunotherapy in Patients With Relapsing Myelitis Without AQP4/MOG Antibodies. Annals of Clinical and Translational Neurology. 12(8). 1689–1692. 1 indexed citations

Kim, Su‐Hyun, Beung‐Chul Ahn, Dong-Eun Lee, et al.. (2024). Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Promising Screening Biomarkers for Brain Metastases in Patients with Lung Cancer. International Journal of Molecular Sciences. 25(12). 6397–6397. 3 indexed citations

Kim, Ki Hoon, Eun Young Park, Ho‐Shin Gwak, et al.. (2024). Disseminating Necrotizing Leukoencephalopathy Associated With Intra-CSF Methotrexate Chemotherapy. Neurology. 102(5). e209167–e209167. 3 indexed citations

Kim, Ki Hoon, Ju‐Hong Min, Seung Woo Kim, et al.. (2024). Immunosuppressive therapy in elderly patients with neuromyelitis optica spectrum disorder: a retrospective multicentre study. Journal of Neurology Neurosurgery & Psychiatry. 95(12). 1168–1175. 4 indexed citations

Kim, Ki Hoon, Su‐Hyun Kim, Na-Young Park, Jae‐Won Hyun, & Ho Jin Kim. (2023). Validation of the International MOGAD Panel proposed criteria. Multiple Sclerosis Journal. 29(13). 1680–1683. 15 indexed citations

Kim, Ki Hoon, Su‐Hyun Kim, Na-Young Park, Jae‐Won Hyun, & Ho Jin Kim. (2022). Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations. Multiple Sclerosis and Related Disorders. 68. 104141–104141. 8 indexed citations

Kim, Ki Hoon, et al.. (2022). Seroprevalence of anti‐myelin oligodendrocyte glycoprotein antibodies in adults with myelitis. Annals of Clinical and Translational Neurology. 9(9). 1481–1486. 3 indexed citations

Kim, Su‐Hyun, Ki Hoon Kim, Jae‐Won Hyun, et al.. (2022). Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers. Frontiers in Oncology. 12. 942960–942960. 15 indexed citations

Hyun, Jae‐Won, Yeseul Kim, & Ho Jin Kim. (2021). Investigation of serum biomarkers for neuropathic pain in neuromyelitis optica spectrum disorder: a preliminary study. 23(1). 46–52. 2 indexed citations

10.

Hyun, Jae‐Won, Hye Lim Lee, Jae-Hong Park, et al.. (2021). Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGAD. Multiple Sclerosis Journal. 28(6). 989–992. 10 indexed citations

11.

Hyun, Jae‐Won, et al.. (2021). Absence of attack-independent neuroaxonal injury in MOG antibody-associated disease: Longitudinal assessment of serum neurofilament light chain. Multiple Sclerosis Journal. 28(6). 993–999. 8 indexed citations

12.

Kim, Yeseul, Ha Eun Kim, Su‐Hyun Kim, et al.. (2021). Functional impairment of CD19 ⁺ CD24 ^hi CD38 ^hi B cells in neuromyelitis optica spectrum disorder is restored by B cell depletion therapy. Science Translational Medicine. 13(624). eabk2132–eabk2132. 10 indexed citations

13.

Kim, Ki Hoon, Su‐Hyun Kim, Na-Young Park, Jae‐Won Hyun, & Ho Jin Kim. (2021). Reappraisal of CSF-specific oligoclonal bands in Asia. Multiple Sclerosis Journal. 28(4). 665–668. 3 indexed citations

14.

Kim, Woojun, Eun Young Park, Jae‐Won Hyun, et al.. (2020). Validation of the Korean Version of the 12-Item Multiple Sclerosis Walking Scale and Application to Neuromyelitis Optica Spectrum Disorder. Journal of Clinical Neurology. 16(2). 270–270. 5 indexed citations

15.

Hyun, Jae‐Won, et al.. (2020). Incidence of interattack asymptomatic brain lesions in NMO spectrum disorder. Neurology. 95(23). e3124–e3128. 30 indexed citations

16.

Hyun, Jae‐Won, Na-Young Park, Su‐Hyun Kim, et al.. (2020). Comparison of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis. Journal of Clinical Neurology. 16(1). 124–124. 17 indexed citations

17.

Choi, Sun Ah, Soo Yeon Kim, Hunmin Kim, et al.. (2020). Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Associated Disease in Korean Children. Journal of Clinical Neurology. 16(3). 461–461. 6 indexed citations

18.

Kim, Su‐Hyun, Yeseul Kim, Ji Yun Jung, et al.. (2019). High Seroprevalence and Index of Anti-John-Cunningham Virus Antibodies in Korean Patients with Multiple Sclerosis. Journal of Clinical Neurology. 15(4). 454–454. 5 indexed citations

19.

Schmidt, F, Friedemann Paul, Marius Ringelstein, et al.. (2018). Ethnic Differences in Clinical Manifestation of Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis Journal. 24. 379–380. 5 indexed citations

20.

Hyun, Jae‐Won, Kichang Kwak, AeRan Joung, et al.. (2016). Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis. European Journal of Neurology. 24(2). 437–445. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact